BioCentury | Jun 19, 2020
Deals

In second innovative deal this month, AbbVie gains option to Alpine’s ‘first-in-class’ lupus program

AbbVie’s deal with Alpine on Thursday is its second innovative partnership in as many weeks, giving the company an option to a Phase II-ready therapy for lupus, a disease that has seen only one targeted...
BioCentury | Nov 15, 2019
Financial News

Despite flurry of deals, follow-ons well short of 2018’s total

Four companies led by Reata raised over $600 million in follow-ons ahead of Thursday’s trading session, but even with the bolus of funding this year’s follow-ons lag last year’s pace. A fifth company, Halozyme Therapeutics...
BioCentury | Nov 6, 2018
Clinical News

Aveo RCC compound trends toward detrimental survival effect, again

Despite announcing plans to submit an NDA to FDA for its renal cell carcinoma compound in about six months, Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) lost $0.51 (20%) to $2.03 on Tuesday after reporting preliminary data late...
BioCentury | Jan 9, 2018
Finance

Stars in China

A major clinical flop and a spate of weak earnings reports by U.S. large cap biotechs reverberated throughout the sector in the fourth quarter, breaking a three-quarter-long streak of outperformance. Across all market cap bands,...
BioCentury | Apr 20, 2017
Clinical News

Acarizax regulatory update

...Denmark Product: Odactra house dust mite (HDM) sublingual allergy immunotherapy (SLIT) ( Miticure - Japan) ( Acarizax - EU) ( MK-8237 , TO-203...
...house dust mite (HDM) sublingual allergy immunotherapy (SLIT) ( Miticure - Japan) ( Acarizax - EU) ( MK-8237 , TO-203) Business: Inflammation Julian Zhu Acarizax house dust mite (HDM) sublingual allergy immunotherapy (SLIT) Miticure MK-8237 TO-203 ALK-Abello...
...Miticure - Japan) ( Acarizax - EU) ( MK-8237 , TO-203) Business: Inflammation Julian Zhu Acarizax house dust mite (HDM) sublingual allergy immunotherapy (SLIT) Miticure MK-8237 TO-203 ALK-Abello A/S Odactra...
BioCentury | Apr 6, 2017
Clinical News

Miticure regulatory update

...ALK-Abello said Torii submitted a regulatory application in Japan to expand the label of Miticure to...
...rhinitis with or without conjunctivitis (see BioCentury, March 10 ). Miticure is also approved as Acarizax...
...Tokyo:4551), Tokyo, Japan Product: House dust mite (HDM) sublingual allergy immunotherapy (SLIT) ( Miticure , Acarizax) ( MK-8237 , TO-203) Business: Inflammation Alex Himes Acarizax house dust mite (HDM) sublingual allergy immunotherapy (SLIT) Miticure MK-8237 TO-203 ALK-Abello...
BioCentury | Mar 10, 2017
Clinical News

House dust mite (HDM) sublingual allergy immunotherapy (SLIT) regulatory update

...Miticure in Japan and Acarizax in Europe and Australia. ALK-Abello A/S (CSE:ALK-B), Horsholm, Denmark Product: Odactra...
...and Acarizax in Europe and Australia. ALK-Abello A/S (CSE:ALK-B), Horsholm, Denmark Product: Odactra house dust mite (HDM) sublingual allergy immunotherapy (SLIT) ( Miticure...
...Horsholm, Denmark Product: Odactra house dust mite (HDM) sublingual allergy immunotherapy (SLIT) ( Miticure , Acarizax) ( MK-8237 , TO-203) Business: Inflammation Nora Weintraub Acarizax house dust mite (HDM) sublingual allergy immunotherapy (SLIT) Miticure MK-8237 TO-203 ALK-Abello...
BioCentury | Aug 1, 2016
Company News

ALK-Abello, Merck deal

...and Ragwitek for ragweed-pollen induced allergic rhinitis. FDA is reviewing a BLA from Merck for MK-8237...
...with a PDUFA date in 2017. ALK-Abello said it will take a greater role in MK-8237’s...
BioCentury | Jul 27, 2016
Company News

Merck ending allergy tablet deal with ALK-Abello

...and Ragwitek for ragweed-pollen induced allergic rhinitis. FDA is reviewing a BLA from Merck for MK-8237...
BioCentury | Apr 18, 2016
Clinical News

House dust mite regulatory update

...FDA accepted for review a BLA from Merck for MK-8237 to treat house dust mite (HDM)-induced...
...2017. The HDM sublingual immunotherapy (SLIT) tablet is approved as Miticure in Japan and as Acarizax...
...Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: House dust mite (HDM) sublingual allergy immunotherapy (SLIT) ( Miticure , Acarizax ) ( MK-8237 , TO-203...
Items per page:
1 - 10 of 95